Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Makoto Hashizume

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5140-0982; OpenAlex author ID A5109896593. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper

Papers 14

  1. Neutrophil extracellular traps promote liver micrometastasis in pancreatic ductal adenocarcinoma via the activation of cancer‑associated fibroblasts. Co-author DOI 10.3892/ijo.2019.4951↗
  2. CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis. Co-author DOI 10.1007/s00432-019-02860-z↗
  3. Robust 3D image reconstruction of pancreatic cancer tumors from histopathological images with different stains and its quantitative performance evaluation. Co-author DOI 10.1007/s11548-019-02019-8↗
  4. Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180. Co-author DOI 10.1016/j.canlet.2017.10.010↗
  5. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.03.031↗
  6. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mi… Co-author DOI 10.1053/j.gastro.2017.01.010↗
  7. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancr… Co-author DOI 10.18632/oncotarget.15430↗
  8. Cancer-associated peritoneal mesothelial cells lead the formation of pancreatic cancer peritoneal dissemination. Co-author DOI 10.3892/ijo.2016.3829↗
  9. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression. Co-author DOI 10.1002/mc.22409↗
  10. Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. Last author DOI 10.1021/mp5007129↗
  11. Mass spectrometry-based metabolic profiling of gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.1097/mpa.0000000000000092↗
  12. Pancreatic Cancer: Clinical Significance of Biomarkers. Co-author DOI 10.1159/000354996↗
  13. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Co-author DOI 10.1245/s10434-012-2252-3↗
  14. MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Co-author DOI 10.1245/s10434-011-1602-x↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenoki Ohuchida · 14 shared papers, 2011–2020 · strength 0.78
  2. Takao Ohtsuka · 11 shared papers, 2011–2020 · strength 0.60
  3. Chika Iwamoto · 7 shared papers, 2017–2020 · strength 0.48
  4. Kohei Nakata · 7 shared papers, 2017–2020 · strength 0.45
  5. Yoshihiro Miyasaka · 7 shared papers, 2017–2020 · strength 0.45
  6. Takashi Okumura · 6 shared papers, 2017–2019 · strength 0.36
  7. Hiromichi Nakayama · 5 shared papers, 2017–2020 · strength 0.34
  8. Shin Takesue · 5 shared papers, 2017–2020 · strength 0.34
  9. Sho Endo · 5 shared papers, 2017–2018 · strength 0.29
  10. Kazuhiro Koikawa · 5 shared papers, 2017–2018 · strength 0.29
  11. Toshiya Abe · 5 shared papers, 2017–2018 · strength 0.29
  12. Masafumi Nakamura · 5 shared papers, 2012–2020 · strength 0.28
  13. Masafumi Nakamura · 4 shared papers, 2017–2019 · strength 0.25
  14. Biao Zheng · 4 shared papers, 2016–2019 · strength 0.24
  15. Yoshinao Oda · 4 shared papers, 2016–2019 · strength 0.24
  16. Masafumi Sada · 4 shared papers, 2017–2018 · strength 0.22
  17. Kohei Horioka · 4 shared papers, 2016–2018 · strength 0.22
  18. Yohei Ando · 3 shared papers, 2018–2020 · strength 0.21
  19. Shin Kibe · 3 shared papers, 2018–2020 · strength 0.21
  20. Masao Tanaka · 5 shared papers, 2011–2016 · strength 0.19
  21. Koji Shindo · 2 shared papers, 2019–2020 · strength 0.16
  22. Yusuke Mizuuchi · 3 shared papers, 2016–2017 · strength 0.16
  23. Masaharu Murata · 3 shared papers, 2014–2017 · strength 0.14
  24. Hidekata Hontani · 1 shared paper, 2019 · strength 0.09
  25. Maurício Kugler · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.